S. 1505 — Introduced in Senate

II 116th CONGRESS 1st Session S. 1505 IN THE SENATE OF THE UNITED STATES May 16, 2019Mr. Cornyn (for himself and Mr. Cardin) introduced the following bill; which was read twice and referred to the Committee on Finance A BILL To require prescription drug plans and MA–PD plans to report potential fraud, waste, and abuse to the Secretary of Health and Human Services under Medicare part D, and for other purposes. 1. Short title This Act may be cited as the Medicare Prescription Drug Fraud Prevention Act of 2019. 2. Requiring prescription drug plans and MA–PD plans to report potential fraud, waste, and abuse to the Secretary of HHS Section 1860D–4 of the Social Security Act (42 U.S.C. 1395w–104) is amended— (1) by redesignating subsection (m) (relating to program integrity transparency measures), as added by section 6063(c) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act (Public Law 115–271), as subsection (n); and (2) by adding at the end the following new subsection: (o) Reporting potential fraud, waste, and abuse Beginning January 1, 2021, the PDP sponsor of a prescription drug plan shall report to the Secretary, as specified by the Secretary— (1) any substantiated or suspicious activities (as defined by the Secretary) with respect to the program under this part as it relates to fraud, waste, and abuse; and (2) any steps made by the PDP sponsor after identifying such activities to take corrective actions. .